Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-09-17 | 2020-09-28 | 124353 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-05-31 | 2024-07-19 | 229430 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-08-09 | 2024-09-13 | 234999 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-02-09 | 2024-04-19 | 219180 |
| APO-ONDANSETRON | 8MG | TABLET | Resolved | 2019-06-05 | 2019-11-11 | 85604 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2024-11-15 | 2024-11-22 | 243181 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2022-11-04 | 2022-12-05 | 173818 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2018-01-08 | 2018-09-29 | 35223 |
| APO-ONDANSETRON | 8MG | TABLET | Resolved | 2021-10-08 | 2022-02-28 | 146907 |
| APO-ONDANSETRON | 8MG | TABLET | Resolved | 2019-08-07 | 2019-11-11 | 91097 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2025-02-20 | 2025-02-28 | 250938 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2017-12-14 | 2018-09-28 | 32822 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2023-07-21 | 2024-03-01 | 199536 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2019-08-07 | 2019-11-11 | 91094 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2022-02-04 | 2022-02-28 | 154184 |
| APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2022-03-07 | 2022-07-15 | 156214 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2021-10-29 | 2022-02-28 | 148509 |
| APO-ONDANSETRON | 8MG | TABLET | Resolved | 2018-03-13 | 2018-09-29 | 42697 |
| APO-OXAPROZIN | 600MG | TABLET | Actual shortage | 2017-03-10 | 2017-10-05 | 411 |
| APO-OXAZEPAM | 10MG | TABLET | Resolved | 2022-07-22 | 2022-09-23 | 165329 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
| APO-TICAGRELOR | 60MG | TABLET | Discontinued | 2025-11-19 | 2025-11-20 | 257747 |
| APO-TICAGRELOR | 60MG | TABLET | To be discontinued | 2025-11-12 | 2025-11-20 | 257700 |
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |